These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 1716432)

  • 21. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis.
    Benson JM; Stuckman SS; Cox KL; Wardrop RM; Gienapp IE; Cross AH; Trotter JL; Whitacre CC
    J Immunol; 1999 May; 162(10):6247-54. PubMed ID: 10229871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin basic protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat.
    Zehetbauer B; Massacesi L; Liuzzi GM; Vergelli M; Olivotto J; Grassi L; Riccio P; Amaducci L
    Acta Neurol (Napoli); 1991 Apr; 13(2):121-32. PubMed ID: 1716398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelin-liposome protection against experimental autoimmune encephalomyelitis is associated with reduced neuroantigen-specific T-cell-mediated responses.
    Stein CS; St Louis J; Strejan GH
    Cell Immunol; 1993 Jan; 146(1):80-95. PubMed ID: 8425233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins.
    Miller SD; Clatch RJ; Pevear DC; Trotter JL; Lipton HL
    J Immunol; 1987 Jun; 138(11):3776-84. PubMed ID: 2438327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.
    Kennedy MK; Tan LJ; Dal Canto MC; Miller SD
    J Immunol; 1990 Jul; 145(1):117-26. PubMed ID: 2358669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
    Chen Y; Inobe J; Weiner HL
    J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis.
    Lennon VA; Westall FC; Thompson M; Ward E
    Eur J Immunol; 1976 Nov; 6(11):805-10. PubMed ID: 63374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
    Schluesener HJ; Sobel RA; Linington C; Weiner HL
    J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
    Nussenblatt RB; Caspi RR; Mahdi R; Chan CC; Roberge F; Lider O; Weiner HL
    J Immunol; 1990 Mar; 144(5):1689-95. PubMed ID: 2137841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
    Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
    Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein in mice.
    Moore GR; McCarron RM; McFarlin DE; Raine CS
    Lab Invest; 1987 Aug; 57(2):157-67. PubMed ID: 2441138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of experimental allergic encephalomyelitis by bacterial lipopolysaccharides: inhibition of cell-mediated immunity.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):13-6. PubMed ID: 6165758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of antisera from Lewis rats immunized with encephalitogenic fragment 43-88 of guinea pig myelin basic protein.
    Fritz RB; Chou CH; Randolph DH; Desjardins AE; Kibler RF
    J Immunol; 1978 Nov; 121(5):1865-9. PubMed ID: 81855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous antigen administration as a therapy for autoimmune demyelinating disease.
    Racke MK; Critchfield JM; Quigley L; Cannella B; Raine CS; McFarland HF; Lenardo MJ
    Ann Neurol; 1996 Jan; 39(1):46-56. PubMed ID: 8572666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
    Stepaniak JA; Gould KE; Sun D; Swanborg RH
    J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.